CNBX Pharmaceuticals, Inc. (CNBX)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
CNBX Pharmaceuticals 30-Day Average Daily Volume : 3.078M for Sept. 18, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 18, 2026 | 3.078M |
| September 17, 2026 | 3.058M |
| September 16, 2026 | 3.013M |
| September 15, 2026 | 2.869M |
| September 14, 2026 | 2.753M |
| September 11, 2026 | 2.716M |
| September 10, 2026 | 2.640M |
| September 09, 2026 | 2.617M |
| September 08, 2026 | 2.548M |
| September 04, 2026 | 1.589M |
| September 03, 2026 | 1.923M |
| September 02, 2026 | 2.131M |
| September 01, 2026 | 2.526M |
| August 31, 2026 | 3.285M |
| August 28, 2026 | 3.368M |
| August 27, 2026 | 3.361M |
| August 26, 2026 | 3.186M |
| August 25, 2026 | 3.217M |
| August 24, 2026 | 4.038M |
| August 21, 2026 | 4.039M |
| August 20, 2026 | 8.593M |
| August 19, 2026 | 15.20M |
| August 18, 2026 | 15.13M |
| August 17, 2026 | 18.46M |
| August 14, 2026 | 18.55M |
| Date | Value |
|---|---|
| August 13, 2026 | 18.62M |
| August 12, 2026 | 19.08M |
| August 11, 2026 | 19.00M |
| August 10, 2026 | 22.75M |
| August 07, 2026 | 22.75M |
| August 06, 2026 | 22.82M |
| August 05, 2026 | 23.97M |
| August 04, 2026 | 24.16M |
| August 03, 2026 | 24.22M |
| July 31, 2026 | 25.11M |
| July 30, 2026 | 29.08M |
| July 29, 2026 | 29.07M |
| July 28, 2026 | 29.26M |
| July 27, 2026 | 29.82M |
| July 24, 2026 | 29.63M |
| July 23, 2026 | 29.29M |
| July 22, 2026 | 29.08M |
| July 21, 2026 | 28.75M |
| July 20, 2026 | 27.97M |
| July 17, 2026 | 27.89M |
| July 16, 2026 | 27.96M |
| July 15, 2026 | 27.98M |
| July 14, 2026 | 27.93M |
| July 13, 2026 | 27.28M |
| July 10, 2026 | 27.68M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Cocrystal Pharma, Inc. | 63672.80 |
| GB Sciences, Inc. | 71811.17 |
| Arvinas, Inc. | 765190.0 |
| Fulcrum Therapeutics, Inc. | 1.610M |
| Definium Therapeutics, Inc. | 2.341M |